FDA approves Jascayd for progressive pulmonary fibrosis

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary fibrosis in adults.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup